Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0.12%277.51M | -2.24%584.49M | 5.23%277.17M | 6.24%597.9M | 0.65%263.39M | -43.11%562.79M | -46.97%261.7M | -7.46%989.2M | -5.98%493.48M | -7.91%1.07B |
| Operating income | 0.12%277.51M | -2.24%584.49M | 5.23%277.17M | 6.24%597.9M | 0.65%263.39M | -43.11%562.79M | -46.97%261.7M | -7.46%989.2M | -5.98%493.48M | -7.91%1.07B |
| Cost of sales | 14.82%-67.57M | -5.82%-172.91M | -12.98%-79.32M | -6.88%-163.41M | -19.83%-70.21M | -2.18%-152.9M | 14.57%-58.59M | -19.55%-149.64M | -53.53%-68.58M | -0.72%-125.17M |
| Other costs | 3.12%-284.6M | 10.16%-586.34M | -26.16%-293.78M | -22.21%-652.64M | -10.38%-232.86M | 39.03%-534.02M | 52.50%-210.97M | 1.28%-875.93M | 7.12%-444.1M | 16.30%-887.32M |
| Operating expenses | 5.61%-352.17M | 6.96%-759.25M | -23.11%-373.1M | -18.80%-816.05M | -12.43%-303.07M | 33.02%-686.91M | 47.42%-269.56M | -1.29%-1.03B | 1.94%-512.69M | 14.51%-1.01B |
| Gross profit | 22.18%-74.66M | 19.89%-174.76M | -141.80%-95.93M | -75.76%-218.15M | -405.29%-39.68M | -241.29%-124.12M | 59.11%-7.85M | -164.38%-36.37M | -1,024.55%-19.2M | 340.52%56.49M |
| Selling expenses | 11.34%-82.24M | -12.09%-234.95M | -31.78%-92.76M | -3.91%-209.62M | 20.24%-70.39M | 25.91%-201.73M | 34.56%-88.25M | 6.42%-272.26M | 14.17%-134.86M | 14.59%-290.94M |
| Operating profit | 16.85%-156.89M | 4.22%-409.71M | -71.44%-188.69M | -31.28%-427.77M | -14.53%-110.06M | -5.58%-325.85M | 37.62%-96.1M | -31.64%-308.63M | 0.64%-154.06M | 35.62%-234.45M |
| Financing income | -4.01%287K | 4.14%780K | -10.48%299K | -32.58%749K | -49.24%334K | -5.61%1.11M | 74.07%658K | 178.25%1.18M | 5.00%378K | -91.31%423K |
| Financing cost | -19.89%-71.28M | -50.61%-125.83M | -67.25%-59.45M | -50.37%-83.55M | -41.82%-35.55M | -19.98%-55.56M | -14.18%-25.07M | -12.24%-46.31M | -1.89%-21.95M | -9.13%-41.26M |
| Special items of earning before tax | 364.54%18.5M | 24.01%-3.09M | -961.31%-6.99M | 92.68%-4.06M | 98.54%-659K | -3,691.71%-55.46M | -1,194.47%-45.13M | 270.26%1.54M | 1,596.71%4.12M | 6.11%417K |
| Earning before tax | 17.84%-209.39M | -4.51%-537.85M | -74.63%-254.84M | -18.10%-514.62M | 11.89%-145.93M | -23.72%-435.75M | 3.43%-165.63M | -28.14%-352.22M | 2.55%-171.51M | 30.71%-274.86M |
| Tax | -7,977.17%-7.43M | 52.98%-15.49M | 97.22%-92K | 82.44%-32.94M | 57.13%-3.31M | -1,540.53%-187.63M | -108.26%-7.71M | -2,086.81%-11.44M | -1,517.47%-3.7M | -82.23%-523K |
| After-tax profit from continuing operations | 14.95%-216.82M | -1.05%-553.34M | -70.82%-254.93M | 12.16%-547.56M | 13.91%-149.24M | -71.42%-623.38M | 1.07%-173.35M | -32.05%-363.65M | 0.57%-175.22M | 30.63%-275.39M |
| After-tax profit from non-continuing business | ---- | ---- | ---- | 84.10%-41.71M | 9.10%-47.75M | ---262.34M | ---52.53M | ---- | ---- | ---- |
| Earning after tax | 14.95%-216.82M | 6.10%-553.34M | -29.41%-254.93M | 33.47%-589.27M | 12.79%-196.99M | -143.56%-885.72M | -28.91%-225.87M | -32.05%-363.65M | 0.57%-175.22M | 30.63%-275.39M |
| Profit attributable to shareholders | 14.95%-216.82M | 6.10%-553.34M | -29.41%-254.93M | 33.47%-589.27M | 12.79%-196.99M | -143.56%-885.72M | -28.91%-225.87M | -32.05%-363.65M | 0.57%-175.22M | 30.63%-275.39M |
| Basic earnings per share | 16.67%-0.03 | 6.02%-0.078 | -28.57%-0.036 | 33.06%-0.083 | 12.50%-0.028 | -143.14%-0.124 | -28.00%-0.032 | -30.77%-0.051 | 0.00%-0.025 | 33.90%-0.039 |
| Diluted earnings per share | 16.67%-0.03 | 6.02%-0.078 | -28.57%-0.036 | 33.06%-0.083 | 12.50%-0.028 | -143.14%-0.124 | -28.00%-0.032 | -30.77%-0.051 | 0.00%-0.025 | 33.90%-0.039 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.